Axplora Invests €50M in GLP-1 Manufacturing Expansion at Mourenx, France

Axplora, GLP-1, manufacturing expansion, Mourenx, France, CDMO, API production, chromatography, diabetes, obesity, biologic therapies

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration